Retatrutide is an experimental peptide for research purposes only
Why they matter: Large randomised cardiovascular and renal outcome trials (EMPA-REG OUTCOME, DAPA-HF, DAPA-CKD, EMPEROR-Reduced/Preserved, CREDENCE, EMPA-KIDNEY) consistently showed reductions in heart-failure hospitalisation, progression of chronic kidney disease, and cardiovascular death
Standard/Brand Name Treatment Plans DO NOT include the price of your medication as it must be purchased by you separately
Does It Increase Cancer Risk
The Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights, giving you a one-time foundation beneath an ongoing protocol
Very easy and quick